Taizhou Central Hospital (Affiliated Hospital of Taizhou University)
Taizhou, Zhejiang, 318000, China
NCT Number: NCT06902935
Construct a breast cancer risk prediction model based on traditional Chinese medicine four diagnostic instruments and B-ultrasound images. Ensure that the key evaluation indicators of the model reach a high level through clinical verification, so as to contribute to accurate clinical diagnosis and treatment decision-making.
Trial opening soon.
Get Notified30 year–75 year
Female
Observational
Taizhou, Zhejiang, 318000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Daosheng TCM Four-Diagnostic Instrument (DS01-A) comprehensively collects patients' TCM four-diagnostic information, covering tongue (e.g., overall color, coating color/thickness/greasiness, tooth marks, etc.), pulse (e.g., position, force, rhythm, etc.), face (e.g., overall color, luster, lip color/dryness, etc.) and constitution scores (quantifying 9 constitutions via the TCM Constitution Classification Table).
Professional ultrasound physicians use B - ultrasound equipment of the same model to accurately collect detailed parameters of breast masses according to a standardized process. These parameters include shape (oval, round, irregular), orientation (parallel, non - parallel), margin (smooth, non - smooth, with non - smooth including blurred, angular, microlobulated, spiculated, etc.), echo pattern (anechoic, hyperechoic, complex cystic - solid echo, hypoechoic, isoechoic, heterogeneous echo), posterior echo characteristics (no change, enhancement, shadowing, mixed), calcification (microcalcification and coarse calcification within the mass, calcification outside the mass, intraductal), and vascular supply (no blood supply, internal blood supply, marginal blood supply), etc.
Time frame: through study completion, an average of 1 year
pale white, pale purple, light red, dark red, dark purple
Time frame: through study completion, an average of 1 year
white, yellow, no tongue coating
Time frame: through study completion, an average of 1 year
Thin tongue coating, thick tongue coating, scanty tongue coating or no tongue coating
Time frame: through study completion, an average of 1 year
forceful, moderate, weak
Time frame: through study completion, an average of 1 year
Regular, rapid intermittent pulse, slow intermittent pulse.
Time frame: through study completion, an average of 1 year
Slow pulse, moderate pulse, normal pulse, rapid pulse, extremely rapid pulse.
Time frame: through study completion, an average of 1 year
Normal facial complexion, white complexion, yellow complexion, red complexion, cyan complexion, black complexion
Time frame: through study completion, an average of 1 year
With luster, without luster
Time frame: through study completion, an average of 1 year
Balanced constitution, Qi-deficiency constitution, Yang-deficiency constitution, Yin-deficiency constitution, Phlegm-dampness constitution, Damp-heat constitution, Blood-stasis constitution, Qi-stagnation constitution, Special constitution.
Contact information is provided by the study sponsor or research team.
Taizhou Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07673588
Breast Cancer, Breast Cancer Screening
View Trial DetailsNCT07541105
Breast Cancer Screening, Breast Diseases
View Trial DetailsNCT07374796
Breast Cancer (Locally Advanced or Metastatic), Breast Cancer Screening
Glen Burnie, Maryland, United States
View Trial DetailsNCT05841355
Breast Cancer Screening
Chicago, Illinois, United States
View Trial Details